Michigan State University Licenses Flu Vaccines To Canadian Company
EAST LANSING ? Michigan State University has cut an exclusive worldwide license agreement with HepaLife Technology of Canada to develop new cell culture-based flu vaccines to protect against the spread of influenza viruses among humans, including bird flu that is sweeping through Asia. The license agreement gives HepaLife exclusive rights to five issued patents. Under